GlassScriptPhysician profile
Lauren A Goddard
NPI 1326300963
$737.04
in general payments reported to CMS, 2019-2025
16 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.79 · 2022: $220 · 2023: $149 · 2024: $150 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $476.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $175.87 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $148.40 | 2022-2024 | Airsupra |
| Novo Nordisk INC | $69.18 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $58.88 | 2021-2023 | Proquad, M-M-R II, Gardasil 9 |
| Ucb, INC. | $48.36 | 2025 | Bimzelx |
| Glaxosmithkline, LLC. | $33.29 | 2022-2025 | Trelegy Ellipta |
| Mayne Pharma Commercial LLC | $29.68 | 2023 | |
| Dexcom, INC. | $24.52 | 2024 | Dexcom G6 Transmitter |
| Amgen INC. | $23.37 | 2024 | Evenity, Prolia |
| Biohaven Pharmaceutical Holding Company LTD. | $23.17 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.71 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.00 | 2025 | Orencia |
| Pfizer INC. | $17.93 | 2022 | |
| Lilly USA, LLC | $16.54 | 2022 | |
| Xeris Pharmaceuticals, INC. | $16.47 | 2023 | Gvoke Hypopen |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Echosens North America, INC. | $9.67 | 2025 | Fibroscan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Goddard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.